These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7566280)

  • 21. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
    Calzetta L; Matera MG; Rogliani P; Cazzola M
    Expert Rev Respir Med; 2018 Aug; 12(8):693-708. PubMed ID: 29972340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stable chronic obstructive pulmonary disease. Published correction for one of studies must be borne in mind.
    Poole P; Black P
    BMJ; 2000 Jan; 320(7230):312-3. PubMed ID: 10722291
    [No Abstract]   [Full Text] [Related]  

  • 23. [Other drugs (not bronchodilators) in COPD].
    García Río F
    Arch Bronconeumol; 2004 Mar; 40 Suppl 1():34-40. PubMed ID: 16137448
    [No Abstract]   [Full Text] [Related]  

  • 24. [N-Acetylcysteine: low and high doses in the treatment of chronic obstructive lung diseases in Chernobyl accident liquidators].
    Chikina SIu; Iagmurov BKh; Kopylev ID; Soodaeva SK; Chuchalin AG
    Ter Arkh; 2002; 74(3):62-5. PubMed ID: 11980127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidation pathway and exacerbations in COPD: the role of NAC.
    Matera MG; Calzetta L; Cazzola M
    Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term therapy of chronic obstructive respiratory tract syndromes].
    Schmidt OP
    Klin Anasthesiol Intensivther; 1976; (12):21-48. PubMed ID: 197297
    [No Abstract]   [Full Text] [Related]  

  • 27. De medicamenteuze behandeling van chronisch obstructieve longziekte [Drug treatment of chronic obstructive lung disease.
    Cabolet P
    Ned Tijdschr Geneeskd; 1996 Aug; 140(33):1705. PubMed ID: 8776959
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current broncholytic and expectorant therapy of patients with chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA; Chuchalin AG
    Ter Arkh; 1987; 59(12):96-9. PubMed ID: 2965833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo.
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1979; 70(1):71-80. PubMed ID: 398153
    [No Abstract]   [Full Text] [Related]  

  • 30. Recommendations for guidelines on clinical trials of mucoactive drugs in chronic bronchitis and chronic obstructive pulmonary disease. Task Group on Mucoactive Drugs.
    Chest; 1994 Nov; 106(5):1532-7. PubMed ID: 7956415
    [No Abstract]   [Full Text] [Related]  

  • 31. [Expectorants, antitussive agents, bronchospasmolytic agents. Therapy of obstructive respiratory tract diseases].
    Haen E
    Med Monatsschr Pharm; 1989 Nov; 12(11):344-55. PubMed ID: 2685526
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acetylcysteine (Fabrol, Mucomyst) in chronic obstructive lung disease/bronchitis].
    Heinig JH; Jørgensen PH
    Ugeskr Laeger; 1984 Apr; 146(16):1229-32. PubMed ID: 6730053
    [No Abstract]   [Full Text] [Related]  

  • 33. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
    Sadowska AM
    Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetylcysteine: multiple clinical applications.
    Millea PJ
    Am Fam Physician; 2009 Aug; 80(3):265-9. PubMed ID: 19621836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease.
    Gerrits CM; Herings RM; Leufkens HG; Lammers JW
    Eur Respir J; 2003 May; 21(5):795-8. PubMed ID: 12765423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Broncholytic and cardiocirculatory effect of methylephedrine and ephedrine].
    Gregori P
    Z Gesamte Inn Med; 1972 Dec; 27(24):1093-7. PubMed ID: 4631892
    [No Abstract]   [Full Text] [Related]  

  • 37. [Letosteine in chronic obstructive bronchopneumopathy].
    Meroni P; Palmieri G; De Bartolo G; Barcellini W; Albrici A; Froldi M
    Clin Ter; 1983 Apr; 105(2):109-18. PubMed ID: 6345052
    [No Abstract]   [Full Text] [Related]  

  • 38. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
    Del Donno M; Olivieri D
    Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease.
    Dekhuijzen PN
    Eur Respir J; 2004 Apr; 23(4):629-36. PubMed ID: 15083766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acetylcysteine in children with lung disorders prescribed by one third of family physicians; no support in the literature].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 1997 Aug; 141(31):1542. PubMed ID: 9543745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.